Total Payments
$3,465
2024 Payments
$285.15
Companies
39
Transactions
198
Medicare Patients
933
Medicare Billing
$49,396
Payment Breakdown by Category
Food & Beverage$3,418 (98.6%)
Education$47.04 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,418 | 194 | 98.6% |
| Education | $47.04 | 4 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $627.32 | 37 | $0 (2023) |
| PFIZER INC. | $329.73 | 29 | $0 (2024) |
| Daiichi Sankyo Inc. | $261.96 | 11 | $0 (2023) |
| Aspira Women's Health Inc | $199.47 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $178.15 | 11 | $0 (2024) |
| Allergan Inc. | $168.63 | 8 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $143.84 | 9 | $0 (2022) |
| Agile Therapeutics, Inc. | $142.36 | 9 | $0 (2023) |
| Avion Pharmaceuticals | $133.61 | 10 | $0 (2022) |
| Amgen Inc. | $111.97 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $285.15 | 15 | Biogen, Inc. ($105.07) |
| 2023 | $908.57 | 38 | Aspira Women's Health Inc ($199.47) |
| 2022 | $510.07 | 28 | Daiichi Sankyo Inc. ($101.84) |
| 2021 | $397.28 | 26 | AbbVie Inc. ($99.39) |
| 2020 | $329.88 | 21 | AbbVie Inc. ($167.85) |
| 2019 | $292.64 | 18 | AbbVie, Inc. ($110.69) |
| 2018 | $354.57 | 21 | AbbVie, Inc. ($91.11) |
| 2017 | $386.89 | 31 | PFIZER INC. ($127.98) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, MYFEMBREE | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: WOMENS HEALTH | ||||||
| 12/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: Biological | ||||||
| 11/18/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Diagnostics | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Biological | ||||||
| 09/17/2024 | Gynesonics, Inc. | SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM | ||||||
| 09/10/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: HORMONE THERAPY | ||||||
| 08/20/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Neurology | ||||||
| 08/08/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Neurology | ||||||
| 07/30/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Neurology | ||||||
| 07/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Biological | ||||||
| 05/28/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Neurology | ||||||
| 05/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Biological | ||||||
| 04/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Hematology | ||||||
| 03/11/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $18.53 | General |
| 01/10/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $8.19 | General |
| Category: ETONOGESTREL | ||||||
| 12/18/2023 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $67.47 | General |
| Category: OB/GYN | ||||||
| 12/13/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: WOMENS HEALTH | ||||||
| 12/11/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Biological | ||||||
| 12/06/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: HORMONE THERAPY | ||||||
| 11/09/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Biological | ||||||
| 10/31/2023 | PFIZER INC. | PREMARIN (Drug), MYFEMBREE, NURTEC ODT | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: WOMENS HEALTH | ||||||
| 10/11/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.41 | General |
| 09/28/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: WOMENS HEALTH | ||||||
| 09/21/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Biological | ||||||
| 08/30/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 248 | 260 | $27,317 | $10,283 |
| 2022 | 6 | 305 | 321 | $40,675 | $13,355 |
| 2021 | 6 | 199 | 217 | $40,487 | $14,360 |
| 2020 | 5 | 181 | 213 | $32,487 | $11,398 |
Total Patients
933
Total Services
1,011
Medicare Billing
$49,396
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 42 | $10,386 | $3,184 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 55 | $9,845 | $3,166 | 32.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 58 | 58 | $3,306 | $2,119 | 64.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 105 | 105 | $3,780 | $1,813 | 48.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 71 | $12,709 | $3,950 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 39 | $9,009 | $3,153 | 35.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 73 | 73 | $4,161 | $2,630 | 63.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 101 | 101 | $3,636 | $1,724 | 47.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $5,544 | $1,168 | 21.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 13 | 13 | $5,616 | $730.04 | 13.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 50 | $11,300 | $4,090 | 36.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 52 | 64 | $11,119 | $3,884 | 34.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 56 | 56 | $3,136 | $2,042 | 65.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,520 | $1,579 | 34.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $4,900 | $1,559 | 31.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 12 | 13 | $5,512 | $1,206 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 58 | 90 | $13,245 | $4,393 | 33.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 64 | 64 | $3,584 | $2,365 | 66.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 28 | $6,276 | $2,179 | 34.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 19 | 19 | $4,294 | $1,443 | 33.6% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 12 | 12 | $5,088 | $1,019 | 20.0% |
About Dr. Ellen Merrick, MD
Dr. Ellen Merrick, MD is a Obstetrics & Gynecology healthcare provider based in Newburgh, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1598760175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ellen Merrick, MD has received a total of $3,465 in payments from pharmaceutical and medical device companies, with $285.15 received in 2024. These payments were reported across 198 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,418).
As a Medicare-enrolled provider, Merrick has provided services to 933 Medicare beneficiaries, totaling 1,011 services with total Medicare billing of $49,396. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Newburgh, IN
- Active Since 06/20/2005
- Last Updated 02/22/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1598760175
Products in Payments
- INJECTAFER (Drug) $261.96
- LO LOESTRIN FE (Drug) $230.40
- Orilissa (Drug) $201.80
- OVA1 (Device) $199.47
- ORILISSA (Drug) $167.86
- PREMARIN (Drug) $165.64
- Twirla (Drug) $142.36
- MYFEMBREE (Drug) $136.74
- Veozah (Drug) $133.66
- Balcoltra (Drug) $115.46
- ORIAHNN (Drug) $97.98
- V-LOC 180 (Device) $92.95
- EVENITY (Biological) $89.17
- ZURZUVAE (Drug) $86.54
- Kyleena (Drug) $85.35
- ESTROGEL (Drug) $74.55
- ESTRING (Drug) $63.02
- Mirena (Drug) $58.49
- ACCRUFER (Drug) $58.23
- PVC (Drug) $55.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Newburgh
Dr. Paul Morrison, M.d., F.a.c.o.g, M.D., F.A.C.O.G
Obstetrics & Gynecology — Payments: $47,311
Obstetrics & Gynecology $47,311
Mr. Charles Werner, Md, MD
Obstetrics & Gynecology — Payments: $15,634
Obstetrics & Gynecology $15,634
Dr. Marcia Cave, Md, MD
Obstetrics & Gynecology — Payments: $11,425
Obstetrics & Gynecology $11,425
Dr. Allen Walker, Md, MD
Obstetrics & Gynecology — Payments: $8,459
Obstetrics & Gynecology $8,459
Melissa Reisinger, Md, MD
Obstetrics & Gynecology — Payments: $6,561
Obstetrics & Gynecology $6,561
Dr. Kimberly Foster, M.d, M.D
Obstetrics & Gynecology — Payments: $6,244
Obstetrics & Gynecology $6,244